Clinical trial
Exhaled Breath Metabolomic Biomarkers in the Acutely Breathless Patient
NCT03672994
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedExhaled Breath Metabolomic Biomarkers in the Acutely Breathless Patient
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Asthmaverified · MONDO: asthma
Heart Failureverified · MONDO: heart failure
Community-acquired Pneumoniaunresolved
Healthyunresolved
Breathlessnessunresolved
Interventions
Sponsors & collaborators
University of Leicesterlead sponsor
Medical Research Councilcollaborator
Loughborough Universitycollaborator
University Hospitals, Leicestercollaborator
Owlstone Ltdcollaborator
B & S ANALYTIK GmbHcollaborator
Advion Biosciences Ltdcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03672994 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.